Skip to main content
. 2016 Jun 29;6:28754. doi: 10.1038/srep28754

Figure 5. Irreversible inhibition of GR activity with 20 μM Bay 11–7082.

Figure 5

Exogenous FAD was added to control samples (lysate of the DMSO-treated erythrocytes) and to identical samples previously treated with Bay 11–7082, parthenolide or dimethyl fumarate (DMF) for 24 h. Differences of identical samples in presence or absence of FAD were analysed by one-way ANOVA comparison and Sidak’s post test.